You are here: Industry Insights > breast

News List

Another Reason Breast Is Best for Fragile Preemie Babies drugs
June 18, 2019
Another Reason Breast Is Best for Fragile Preemie Babies.
CytoDyn Evaluates Leronlimab for Triple-Negative Breast Cancer contractpharma
June 12, 2019
FDA grants CytoDyn Fast Tract Designation to evaluate leronlimab in combination with carboplatin for the treatment of triple-negative breast cancer.
Data Insufficient for Safety of Lithium During Breastfeeding drugs
June 11, 2019
Data Insufficient for Safety of Lithium During Breastfeeding.
Surveillance Breast MRI Ups Biopsy, Cancer Detection Rates drugs
June 06, 2019
Surveillance Breast MRI Ups Biopsy, Cancer Detection Rates.
Is MRI Screening Worth It for Breast Cancer Survivors? drugs
June 05, 2019
Breast MRI screening is a good way to detect small tumors, but it's unclear how much it benefits women with a history of breast cancer, a new study finds.
ASCO: Survival Up With Ribociclib in Advanced Breast Cancer drugs
June 05, 2019
Survival Up With Ribociclib in Advanced Breast Cancer.
BluePrint® Identifies Genomic Subtypes for African-American Breast Cancer Patients with Low Risk Outcomes b3cnewswire
June 03, 2019
BluePrint® Identifies Genomic Subtypes for African-American Breast Cancer Patients with Low Risk Outcomes.
Newer Drug Extends Lives of Young Breast Cancer Patients drugs
June 03, 2019
Adding a newer drug to standard hormone therapy lengthens the lives of younger women with advanced breast cancer, a new trial has found.
FDA Approves Piqray (alpelisib) as First PI3K Inhibitor for Breast Cancer drugs
May 31, 2019
FDA Approves Piqray.
First PI3K inhibitor for breast cancer approved by FDA europeanpharmaceuticalreview
May 30, 2019
The US Food and Drug Administration (FDA) has approved Piqray (alpelisib) tablets to treat patients with breast cancer.

Previous page 1 2 3 4 5 6 Next page